Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Sep 30, 2025 | (FY)Mar 31, 2025 | (Q6)Sep 30, 2024 | (FY)Mar 31, 2024 | (Q6)Sep 30, 2023 | (FY)Mar 31, 2023 | (Q6)Sep 30, 2022 | (FY)Mar 31, 2022 | (Q6)Sep 30, 2021 | (FY)Mar 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 36.21%857.17M | 20.90%1.19B | 55.10%629.3M | 49.13%984.29M | 5.05%405.74M | -36.69%660.01M | -15.74%386.22M | -16.01%1.04B | -15.67%458.37M | -7.19%1.24B |
| Operating income | 36.21%857.17M | 20.90%1.19B | 55.10%629.3M | 49.13%984.29M | 5.05%405.74M | -36.69%660.01M | -15.74%386.22M | -16.01%1.04B | -15.67%458.37M | -7.19%1.24B |
| Cost of sales | -35.91%-842.17M | -24.14%-1.18B | -56.70%-619.64M | -44.57%-947.97M | -1.28%-395.42M | 34.73%-655.73M | 10.90%-390.44M | 15.30%-1B | 15.54%-438.21M | 9.25%-1.19B |
| Operating expenses | -35.91%-842.17M | -24.14%-1.18B | -56.70%-619.64M | -44.57%-947.97M | -1.28%-395.42M | 34.73%-655.73M | 10.90%-390.44M | 15.30%-1B | 15.54%-438.21M | 9.25%-1.19B |
| Gross profit | 55.14%14.99M | -63.75%13.17M | -6.33%9.67M | 748.21%36.33M | 344.56%10.32M | -88.66%4.28M | -120.93%-4.22M | -31.33%37.75M | -18.48%20.16M | 81.48%54.98M |
| Selling expenses | 22.23%-10.81M | -13.24%-28.74M | -17.54%-13.9M | -53.10%-25.38M | -166.92%-11.82M | -62.99%-16.58M | -8.98%-4.43M | 7.76%-10.17M | 24.48%-4.06M | 15.96%-11.03M |
| Administrative expenses | -2.70%-34.28M | -11.90%-68.74M | -7.75%-33.38M | -4.74%-61.43M | -12.77%-30.98M | 4.55%-58.65M | 21.87%-27.47M | 30.93%-61.45M | 18.66%-35.16M | -5.14%-88.97M |
| Revaluation surplus | -3,826.61%-4.06M | 64.60%-5.9M | 101.40%109K | 38.71%-16.66M | 22.25%-7.77M | -223.22%-27.18M | -629.78%-10M | 261.24%22.05M | -198.21%-1.37M | 34.92%-13.68M |
| -Changes in the fair value of investment property | ---- | 19.26%-8.74M | ---- | 17.09%-10.83M | ---- | -276.08%-13.06M | ---- | 72.24%7.42M | ---- | 289.81%4.31M |
| -Changes in the fair value of financial assets | -3,826.61%-4.06M | 148.76%2.84M | 101.40%109K | 58.70%-5.83M | 22.25%-7.77M | -196.45%-14.12M | -629.78%-10M | 181.40%14.64M | -198.21%-1.37M | 4.09%-17.98M |
| Impairment and provision | ---- | 35.87%-11.69M | ---- | -74.97%-18.23M | ---- | 68.44%-10.42M | ---- | -2,801.67%-33.02M | ---- | ---1.14M |
| -Other impairment is provision | ---- | 35.87%-11.69M | ---- | -74.97%-18.23M | ---- | 68.44%-10.42M | ---- | -2,801.67%-33.02M | ---- | ---1.14M |
| Operating interest expense | ---- | ---- | ---- | ---- | ---- | -429.89%-461K | -57.89%-60K | 91.04%-87K | 95.66%-38K | 74.20%-971K |
| Special items of operating profit | -112.18%-1.09M | -58.97%4.64M | 192.20%8.95M | -62.76%11.31M | 64.85%3.06M | 147.93%30.37M | -64.41%1.86M | -40.33%12.25M | -28.87%5.22M | 441.72%20.53M |
| Operating profit | -23.44%-35.25M | -31.32%-97.26M | 23.23%-28.55M | 5.81%-74.06M | 16.08%-37.2M | -140.67%-78.63M | -190.60%-44.32M | 18.89%-32.67M | 4.77%-15.25M | 54.46%-40.28M |
| Financing cost | 78.70%-663K | -40.19%-4.26M | -134.34%-3.11M | ---3.04M | ---1.33M | ---- | ---- | ---- | ---- | ---- |
| Share of profits of associates | ---- | ---976K | ---- | ---- | ---- | -25.95%-4.31M | -108.97%-2.42M | -2,561.87%-3.42M | -5,423.81%-1.16M | 131.59%139K |
| Share of profit from joint venture company | 11.80%98.49M | -16.85%155.81M | 25.29%88.09M | 51.38%187.38M | -17.65%70.31M | -54.51%123.78M | -41.22%85.38M | -14.12%272.13M | 24.95%145.26M | 74.73%316.86M |
| Earning before tax | 10.90%62.58M | -51.66%53.31M | 77.52%56.43M | 170.03%110.28M | -17.73%31.79M | -82.70%40.84M | -70.01%38.64M | -14.70%236.03M | 28.56%128.85M | 199.28%276.72M |
| Tax | -18.02%-131K | 135.87%401K | 25.00%-111K | -808.94%-1.12M | -72.09%-148K | 97.55%-123K | 96.14%-86K | 30.30%-5.01M | -1,640.63%-2.23M | -320.34%-7.19M |
| After-tax profit from continuing operations | 10.89%62.45M | -50.79%53.71M | 78.00%56.32M | 168.10%109.16M | -17.93%31.64M | -82.37%40.72M | -69.55%38.55M | -14.29%231.02M | 26.50%126.62M | 197.00%269.53M |
| Earning after tax | 10.89%62.45M | -50.79%53.71M | 78.00%56.32M | 168.10%109.16M | -17.93%31.64M | -82.37%40.72M | -69.55%38.55M | -14.29%231.02M | 26.50%126.62M | 197.00%269.53M |
| Minority profit | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 90.27%-262K |
| Profit attributable to shareholders | 10.89%62.45M | -50.79%53.71M | 78.00%56.32M | 168.10%109.16M | -17.93%31.64M | -82.37%40.72M | -69.55%38.55M | -14.37%231.02M | 25.60%126.62M | 188.72%269.79M |
| Basic earnings per share | 10.81%0.0687 | -50.79%0.0591 | 78.16%0.062 | 168.08%0.1201 | -17.92%0.0348 | -82.38%0.0448 | -69.58%0.0424 | -14.38%0.2542 | 25.70%0.1394 | 188.81%0.2969 |
| Diluted earnings per share | 10.81%0.0687 | -50.79%0.0591 | 78.16%0.062 | 168.08%0.1201 | -17.92%0.0348 | -82.38%0.0448 | -69.58%0.0424 | -14.38%0.2542 | 25.70%0.1394 | 188.81%0.2969 |
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Ernst & Young Accounting Firm | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young Accounting Firm | -- | Ernst & Young Accounting Firm |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.